186 related articles for article (PubMed ID: 24169359)
21. [Performances of breast magnetic resonance imaging in the context of neoadjuvant chemotherapy for breast cancer to predict pathological complete response].
Brisson C; Diguisto C; Vildé A; Body G; Arbion F; Leveque J; Ouldamer L
J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):147-154. PubMed ID: 28403971
[TBL] [Abstract][Full Text] [Related]
22. Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response.
Preibsch H; Wanner L; Bahrs SD; Wietek BM; Siegmann-Luz KC; Oberlecher E; Hahn M; Staebler A; Nikolaou K; Wiesinger B
Eur Radiol; 2016 Jun; 26(6):1590-6. PubMed ID: 26382845
[TBL] [Abstract][Full Text] [Related]
23. Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.
Henderson S; Purdie C; Michie C; Evans A; Lerski R; Johnston M; Vinnicombe S; Thompson AM
Eur Radiol; 2017 Nov; 27(11):4602-4611. PubMed ID: 28523352
[TBL] [Abstract][Full Text] [Related]
24. Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden.
Asano Y; Kashiwagi S; Goto W; Takada K; Takahashi K; Hatano T; Noda S; Takashima T; Onoda N; Tomita S; Motomura H; Ohsawa M; Hirakawa K; Ohira M
BMC Cancer; 2017 Dec; 17(1):888. PubMed ID: 29282021
[TBL] [Abstract][Full Text] [Related]
25. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.
Sutton EJ; Onishi N; Fehr DA; Dashevsky BZ; Sadinski M; Pinker K; Martinez DF; Brogi E; Braunstein L; Razavi P; El-Tamer M; Sacchini V; Deasy JO; Morris EA; Veeraraghavan H
Breast Cancer Res; 2020 May; 22(1):57. PubMed ID: 32466777
[TBL] [Abstract][Full Text] [Related]
26. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
[TBL] [Abstract][Full Text] [Related]
27. Shear wave elastography of tumour growth in a human breast cancer model with pathological correlation.
Chamming's F; Latorre-Ossa H; Le Frère-Belda MA; Fitoussi V; Quibel T; Assayag F; Marangoni E; Autret G; Balvay D; Pidial L; Gennisson JL; Tanter M; Cuenod CA; Clément O; Fournier LS
Eur Radiol; 2013 Aug; 23(8):2079-86. PubMed ID: 23553589
[TBL] [Abstract][Full Text] [Related]
28. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
An YY; Kim SH; Kang BJ
World J Surg Oncol; 2017 Nov; 15(1):198. PubMed ID: 29110671
[TBL] [Abstract][Full Text] [Related]
29. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?
Maier AM; Heil J; Harcos A; Sinn HP; Rauch G; Uhlmann L; Gomez C; Stieber A; Funk A; Barr RG; Hennigs A; Riedel F; Schäfgen B; Hug S; Marmé F; Sohn C; Golatta M
Eur J Radiol; 2020 Jul; 128():109025. PubMed ID: 32371182
[TBL] [Abstract][Full Text] [Related]
30. Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients.
Romero A; García-Sáenz JA; Fuentes-Ferrer M; López Garcia-Asenjo JA; Furió V; Román JM; Moreno A; de la Hoya M; Díaz-Rubio E; Martín M; Caldés T
Ann Oncol; 2013 Mar; 24(3):655-61. PubMed ID: 23104719
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of axillary nodal imaging by magnetic resonance imaging based on breast cancer subtype after neoadjuvant chemotherapy.
Steiman J; Soran A; McAuliffe P; Diego E; Bonaventura M; Johnson R; Ahrendt G; McGuire K
J Surg Res; 2016 Jul; 204(1):237-41. PubMed ID: 27451892
[TBL] [Abstract][Full Text] [Related]
32. Shear-wave elastography and immunohistochemical profiles in invasive breast cancer: evaluation of maximum and mean elasticity values.
Ganau S; Andreu FJ; Escribano F; Martín A; Tortajada L; Villajos M; Baré M; Teixidó M; Ribé J; Sentís M
Eur J Radiol; 2015 Apr; 84(4):617-22. PubMed ID: 25619502
[TBL] [Abstract][Full Text] [Related]
33. Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore.
Laas E; Labrosse J; Hamy AS; Benchimol G; de Croze D; Feron JG; Coussy F; Balezeau T; Guerin J; Lae M; Pierga JY; Reyal F
Br J Cancer; 2021 Apr; 124(8):1421-1427. PubMed ID: 33558711
[TBL] [Abstract][Full Text] [Related]
34. Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.
Tanioka M; Sasaki M; Shimomura A; Fujishima M; Doi M; Matsuura K; Sakuma T; Yoshimura K; Saeki T; Ohara M; Tsurutani J; Watatani M; Takano T; Kawabata H; Mukai H; Naito Y; Hirokaga K; Takao S; Minami H
Breast; 2014 Aug; 23(4):466-72. PubMed ID: 24742606
[TBL] [Abstract][Full Text] [Related]
35. Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.
Namura M; Tsunoda H; Yagata H; Hayashi N; Yoshida A; Morishita E; Takei J; Suzuki K; Yamauchi H
Clin Breast Cancer; 2018 Apr; 18(2):128-134. PubMed ID: 28843513
[TBL] [Abstract][Full Text] [Related]
36. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Peintinger F; Kuerer HM; McGuire SE; Bassett R; Pusztai L; Symmans WF
Br J Surg; 2008 Apr; 95(4):433-7. PubMed ID: 18161887
[TBL] [Abstract][Full Text] [Related]
37. Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?
Evans A; Rauchhaus P; Whelehan P; Thomson K; Purdie CA; Jordan LB; Michie CO; Thompson A; Vinnicombe S
Breast Cancer Res Treat; 2014 Jan; 143(1):153-7. PubMed ID: 24305976
[TBL] [Abstract][Full Text] [Related]
38. The Prognostic Impact of Early Change in 18F-FDG PET SUV After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer.
Lee HW; Lee HM; Choi SE; Yoo H; Ahn SG; Lee MK; Jeong J; Jung WH
J Nucl Med; 2016 Aug; 57(8):1183-8. PubMed ID: 27033896
[TBL] [Abstract][Full Text] [Related]
39. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.
Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V
Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527
[TBL] [Abstract][Full Text] [Related]
40. High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer.
Wang Y; Sparano JA; Fineberg S; Stead L; Sunkara J; Horwitz SB; McDaid HM
Clin Breast Cancer; 2013 Apr; 13(2):103-8. PubMed ID: 23218766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
